Effect of adapalene on cetuximab-induced painful periungual inflammation

Journal of the American Academy of Dermatology

Volumn 64, Issue 2, 2011, Pages

  Hachisuka, Junichi ^a,b   Yunotani, Seiji ^a   Shidahara, Satoshi ^a   Moroi, Yoichi ^b   Furue, Masutaka ^b  

^a KARATSU RED CROSS HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; BETAMETHASONE DERIVATIVE; BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MINOCYCLINE; OXALIPLATIN; ZINC OXIDE;

ABSENCE OF SIDE EFFECTS; ADULT; CANCER CHEMOTHERAPY; CASE REPORT; HUMAN; INFLAMMATION; LETTER; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NAIL DISEASE; PRIORITY JOURNAL; RASH; RECTUM CANCER; TOE; TREATMENT OUTCOME;

EID: 78751508129     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.12.019     Document Type: Article

References (5)

1. T. Li, and R. Pérez-Soler Skin toxicities associated with epidermal growth factor receptor inhibitors Targ Oncol 4 2009 107 119
2. A. Scope, J.A. Lieb, S.W. Dusza, D.L. Phelan, P.L. Myskowski, and L. Saltz A prospective randomized trial of topical pimecrolimus for cetuximab-associated acne-like eruption J Am Acad Dermatol 61 2009 614 620
3. R. Gutzmer, T. Werfel, R. Mao, A. Kapp, and J. Elsner Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy Br J Dermatol 153 2005 849 851
4. M.E. Lacouture Mechanisms of cutaneous toxicities to EGFR inhibitors Nat Rev Cancer 10 2006 803 812
5. L. Rittié, J. Varani, S. Kang, J.J. Voorhees, and G.J. Fisher Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo J Invest Dermatol 126 2006 732 739